Introduction {#S1}
============

A mutually beneficial relationship has been evolutionarily shaped in the mammalian gut between the host and the complex communities of commensal microorganisms, collectively called as the "microbiota". Misbalanced host-microbiota interactions are considered to underlie the pathogenesis of Inflammatory Bowel Diseases (IBD), chronic inflammatory disorders of the intestine with two major forms, Crohn\'s disease and ulcerative colitis.^[@R1]^ Crohn\'s disease is manifested primarily in the terminal ileum, a part of the intestinal tract which provides a unique microenvironment for the growth of microbial communities. Contrary to the large bowel, the ileum is characterized by the formation of a single-layered and porous mucus barrier which is penetrant to bacteria.^[@R2]^ Antimicrobial peptides secreted by Paneth cells localized at the basal part of the crypts and an extensive network of lymphoid tissues, including Peyer\'s patches and isolated lymphoid follicles, provide antimicrobial clearance and immunosurveillance.^[@R3],\ [@R4]^ Furthermore, the composition of mucosa-associated microbial populations in the ileum significantly differs from that of the colon both in healthy humans and in IBD patients,^[@R5]^ whereas a series of studies has established that Crohn\'s disease is associated with dysbiosis.^[@R6]^ A recent relevant study showed that treatment-naive pediatric Crohn\'s disease associates with enrichment of *Enterobacteriaceae* and depletion of Clades IV and XIVa of *Clostridia* in the mucosa of the terminal ileum.^[@R7]^ Apart from these microbial alterations associated with disease, genome-wide association studies (GWAS) have indicated several microbial recognition and host defense genes as associated with both Crohn\'s disease and ulcerative colitis.^[@R8]^ For example, risk alleles in *NOD2* and *ATG16L1* genes lead in an additive manner to an abnormal Paneth cell phenotype in Crohn\'s disease patients,^[@R9]^ indicative of a possible implication of defective microbial clearance in pathogenesis. Although recent progress in Crohn\'s disease genetics and microbiome analysis strengthens the concept that misbalanced host-microbiota interactions underlie pathogenesis and also establish the development of a dysbiotic microbiota as a key feature associated with pathology, the causalities in abnormal host-microbiota interactions with regard to Crohn\'s disease pathogenesis remain unknown.

Mouse models of IBD are essential for the understanding of mechanisms implicating host-microbiota interactions in human disease; however, relevant studies have been restricted in colitis models so far.^[@R10]^ *Tnf^ΔARE/+^* mice chronically overproduce TNF and spontaneously develop a fully penetrant Crohn\'s-like IBD pathology localized specifically in the terminal ileum and occasionally also in the proximal colon.^[@R11]^ *Tnf^ΔARE/+^* mice display typical histopathological features of human Crohn\'s disease such as massive infiltration of acute and chronic effector cells in the lamina propria (LP), villi blunting and development of transmural inflammation.^[@R11]^ Local overexpression of TNF in the gut specifically by intestinal epithelial cells (IECs) is sufficient to induce full-blown Crohn\'s-like IBD pathology in this model.^[@R12]^ Thus, the *Tnf^ΔARE^* model is an ideal tool for the study of intestinal epithelial responses to luminal bacteria and vice versa, in a disease context sharing many common characteristics with human Crohn\'s disease.

Here, we study host-microbiota interactions in murine modeled Crohn\'s disease and demonstrate that pathology in *Tnf^ΔARE/+^* mice depends on the presence of the commensal microbiota which is required for TNF overexpression in the intestine. We also evidence epithelial alterations occurring in established but not in early disease in *Tnf^ΔARE/+^* mice and show that a dysbiotic microbiota is shaped in diseased mice. Our results suggest that commensals are sufficient to initiate Crohn\'s disease pathogenesis in the presence of proinflammatory genetic alterations whereas an overall dysbiotic microbiota with significant alterations at the level of phyla develops in the inflamed mucosa secondarily to disease and is not required for disease initiation.

Results {#S2}
=======

Crohn\'s-like IBD pathology and disease-initiating TNF overexpression in the intestine of *Tnf^ΔARE/+^* mice depend on the presence of bacteria {#S3}
-----------------------------------------------------------------------------------------------------------------------------------------------

To examine the role of the intestinal microbiota in Crohn\'s disease pathogenesis we generated germ-free *Tnf^ΔARE/+^* mice and compared disease development to *Tnf^ΔARE/+^* mice reared under Specific Pathogen Free (SPF) conditions. Strikingly, germ-free *Tnf^ΔARE/+^* mice were completely protected from IBD pathology showing no signs of inflammatory infliltration or villi blunting in the terminal ileum as evidenced by histological analysis at the age of 15 weeks, an age when *Tnf^ΔARE/+^* mice show fully developed IBD pathology.^[@R13]^ In sharp contrast to germ-free *Tnf^ΔARE/+^* mice, Crohn\'s-like pathology was readily evidenced in the ileum of 11-week-old control *Tnf^ΔARE/+^* mice originating from the same mouse colony and raised under identical but non-sterile, specific-pathogen-free (SPF) housing conditions ([Figure 1a, b](#F1){ref-type="fig"}). These results demonstrate that the development of Crohn\'s-like IBD pathology in *Tnf^ΔARE/+^* mice is microbiota-dependent. The complete microbial dependence of intestinal pathology in *Tnf^ΔARE/+^* mice suggests a possible implication of the microbiota in the very early events driving pathogenesis in this model, which are related to TNF overproduction. Relevantly, we have previously established that IECs are a major local source of early TNF overexpression in *Tnf^ΔARE/+^* mice and that mice engineered to overexpress TNF specifically by IECs develop full Crohn\'s-like IBD pathogenesis in the ileum.^[@R12]^ We examined the necessity of the intestinal microbiota in ileal TNF overexpression, by performing RT-PCR analysis in the ileum showing significantly higher TNF expression levels in the ileum of SPF compared to germ-free *Tnf^ΔARE/+^* mice ([Figure 1c](#F1){ref-type="fig"}). These results show that microbial signals are necessary for the induction of aberrant TNF expression in the intestine, a condition sufficient for disease initiation in this model. Since innate recognition of the microbiota by several TLRs (Toll-like receptors) initiates signaling cascades through the Myd88 adaptor molecule and activates cytokine production, including TNF,^[@R14]^ we hypothesized that Myd88-mediated innate signaling may play a central role in IBD pathogenesis in the *Tnf^ΔARE^* model. Indeed, *Tnf^ΔARE/+^Myd88^-/-^* mice examined at the age of 16 weeks, a stage when fully-developed disease is observed,^[@R13]^ showed a significantly attenuated IBD pathology compared to *Tnf^ΔARE/+^* littermate controls, characterized by less inflammatory infiltration in the ileal mucosa and the submucosa and showing no signs of transmural inflammation, as it was the case for *Tnf^ΔARE/+^* controls ([Figure 2a, b](#F2){ref-type="fig"}). To examine whether Myd88 is required for TNF overexpression in *Tnf^ΔARE/+^* mice, we isolated peritoneal macrophages from *Tnf^ΔARE/+^*, *Tnf^ΔARE/+^Myd88^-/-^,Myd88^-/-^* and WT control mice and measured TNF secretion in response to LPS stimulation. Macrophages isolated from *Tnf^ΔARE/+^Myd88^-/-^* mice showed defective LPS-induced TNF secretion compared to *Tnf^ΔARE/+^* macrophages and reached levels similar to that of WT macrophages ([Figure 2c](#F2){ref-type="fig"}). This suggests that innate response to LPS through Myd88 drives TNF overexpression and subsequently mediates IBD pathogenesis in *Tnf^ΔARE/+^* mice. These results establish that TLR/Myd88-mediated innate recognition is required for TNF-driven IBD pathology development, in contrast to the homeostatic role established for TLR/Myd88 signaling in epithelial-injury induced colitis,^[@R15]^ and also indicate the presence of additional, Myd88-independent, innate pathways mediating TNF-driven murine Crohn\'s-like pathogenesis.

The inflamed ileum of *Tnf^ΔARE/+^* mice is characterized by epithelial alterations involving loss of lysozyme-expressing Paneth cells and defective antimicrobial responses {#S4}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

High resolution endoscopy performed in the terminal ileum of diseased *Tnf^ΔARE/+^* mice showed intestinal villi with increased diameter and an irregular shape, an observation consistent with the increased inflammatory infiltration in the LP in this model ([Figure 3a](#F3){ref-type="fig"}). The intestinal epithelium of diseased *Tnf^ΔARE/+^* mice is also characterized by accumulation of αE^+^CD8αβ^+^ effector intraepithelial T-lymphocytes ([Figure 3b](#F3){ref-type="fig"}). We have previously shown that these cells home to the ileum in a αEβ7 integrin-dependent manner where they predominate over the resident non-conventional TCRγδ and TCRαβCD8αα T-lymphocytes and express interferon (IFN)-γ and TNF.^[@R16]^ To examine the possible effects of cytokine-expressing immune effectors on intestinal epithelial functions we characterized barrier properties, epithelial cell type populations and gene expression in the intestinal epithelium of diseased *Tnf^ΔARE/+^* mice. TNF and IFN-γ have been suggested to promote a leaky paracellular transport of solutes across the intestinal epithelium.^[@R17]^ We examined the possible presence of gross defects in paracellular epithelial barrier permeability in the terminal ileum of diseased *Tnf^ΔARE/+^* mice by measuring blood to lumen ^51^Cr-EDTA clearance. No difference was found between *Tnf^ΔARE/+^* mice and WT littermates in the paracellular permeability for this ∼400 kD large molecule in the ileum ([Figure 3c](#F3){ref-type="fig"}). In addition, no significant difference was found in the lumen to blood permeability of orally-administered 20kDa FITC-dextran ([Figure 3d](#F3){ref-type="fig"}). Although malfunctions in the paracellular epithelial barrier in *Tnf^ΔARE/+^* mice cannot be generally excluded based on these experiments, these argue against the presence of major defects permitting the passage of \>20kDa luminal molecules. At the level of transcellular ion transport and ion channel function, we have previously reported defects in bicarbonate secretion and fluid absorption in the ileum of *Tnf^ΔARE/+^* mice which may affect luminal pH and gut microbiota composition in these mice.^[@R18]^ The reduced fluid absorption in the ileum is compensated in the colon of *Tnf^ΔARE/+^* mice,^[@R18]^ thus no diarrhea is observed ([Figure 3e](#F3){ref-type="fig"}). Quantification of Goblet cells per villus by Periodic acid-Schiff staining (PAS) showed no difference between diseased *Tnf^ΔARE/+^* and WT control mice ([Figure 3f](#F3){ref-type="fig"}). Furthermore, mucin 2 secretion by Goblet cells was also found similar between *Tnf^ΔARE/+^* mice and WT controls ([Figure 3g](#F3){ref-type="fig"}). These results suggest that no major defects occur in the formation of the mucus barrier in the inflamed ileum of *Tnf^ΔARE/+^* mice. In contrast, Paneth cell quantification by immunostaining using anti-lysozyme antibodies revealed significantly reduced lysozyme-expressing Paneth cell numbers per crypt in the ileum of *Tnf^ΔARE/+^* mice at the age of 8 and 16 weeks, an intermediate and a full-blown disease stage respectively ([Figure 4a](#F4){ref-type="fig"}). 16 week-old *Tnf^ΔARE/+^* mice show significantly reduced Paneth cells compared to 8 week-old *Tnf^ΔARE/+^* mice, indicative of an association between pathology stage and Paneth cell numbers. In addition, 8-week-old *Tnf^ΔARE/+^* mice showed significantly reduced Paneth cell numbers in crypts surrounded by extensive submucosal inflammation as compared to crypts located in areas where inflammation is less extensive or restricted in the mucosa ([Figure 4b](#F4){ref-type="fig"}). These results show that disease progression in *Tnf^ΔARE/+^* mice is associated with Paneth cell loss as assessed by immunostaining agaist lysozyme. To examine whether adaptive immune system effectors are required for this effect we examined Paneth cell numbers in alymphoid *Tnf^ΔARE/+^Rag1^-/-^* mice. *Tnf^ΔARE/+^Rag1^-/-^* mice show strongly attenuated pathology but also persistent infiltration of neutrophils in the LP and villi blunting.^[@R13]^ Quantification of Paneth cells by immunostaining against lysozyme in 16 week-old *Tnf^ΔARE/+^Rag1^-/-^* mice showed significantly attenuated Paneth cell loss in their ileal crypts when compared to *Tnf^ΔARE/+^* mice, to values approximating those of WT animals ([Supplementary Figure 1a, c](#SD1){ref-type="supplementary-material"}). In agreement with the previously described infiltration of neutrophils in the latter,^[@R13]^ lysozyme-producing inflammatory cells were observed in the LP of both *Tnf^ΔARE/+^* and *Tnf^ΔARE/+^Rag1^-/-^* mice ([Supplementary Figure 1a](#SD1){ref-type="supplementary-material"}). Thus, adaptive immune system effectors are essential for Paneth cell loss in *Tnf^ΔARE/+^* mice whereas innate inflammatory infiltrates appear not to be sufficient to mediate Paneth cell loss. Furthermore, lysozyme immunostainings in 16 week-old *Tnf^ΔARE/+^Ifng^-/-^* mice, which also display an attenuated pathology,^[@R13]^ showed a significantly attenuated Paneth cell loss compared to *Tnf^ΔARE/+^* littermate controls ([Supplementary Figure 1b, c](#SD1){ref-type="supplementary-material"}). These results indicate a role of IFN-γ-secreting adaptive immune effector cells in Paneth cell reduction in *Tnf^ΔARE/+^* mice. Whether this is a direct effect of IFN-γ via its receptor on Paneth cells needs further investigation. Paneth cell-specific targeting of IFN-γ receptor may clarify this issue.

To examine the functional consequences of Paneth cell loss in the epithelium of *Tnf^ΔARE/+^* mice we tested antimicrobial responses since these cells are a major source of antimicrobial peptides in the small intestine. RT-PCR analysis performed in the ileum of 8 week-old *Tnf^ΔARE/+^* mice and littermate WT controls for a panel of antimicrobial genes showed significantly decreased expression levels for the alpha defensin genes (*Defa*) *Defa21* and *Defa29*, the complement receptor type 2 (*CR2*) and the lysozyme-encoding gene *Lyzc1* in *Tnf^ΔARE/+^* mice ([Figure 4c, d](#F4){ref-type="fig"}). These results suggest that IBD pathology in *Tnf^ΔARE/+^* mice is associated with diminished antimicrobial gene expression, in agreement with the loss of Paneth cells observed in these mice. To compare the above findings with inflammation levels, we measured gene expression levels of *Tnf*, the major driver of inflammation and pathogenesis in *Tnf^ΔARE/+^* mice. In agreement with our previous results on an early local *Tnf* overexpression before disease onset in this model,^[@R12]^ *Tnf^ΔARE/+^* mice showed increased *Tnf* expression in the ileum compared to their WT littermates at 4, 8 and 18 weeks of age ([Figure 4e](#F4){ref-type="fig"}).

Dysbiosis, increased abundance of Segmented Filamentous Bacteria and increased epithelial attachment of bacteria in the terminal ileum of diseased *Tnf^ΔARE/+^* mice {#S5}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Antimicrobial peptides can affect the composition of the intestinal microbiota.^[@R19]^ To determine if alterations in the expression of antimicrobial peptides and/or bicarbonate secretion defects observed in *Tnf^ΔARE/+^* mice altered the composition of the microbiome, we analyzed the mucosa-associated microbiome in the distal ileum of *Tnf^ΔARE/+^* and co-housed WT control littermates by 16S rDNA sequencing.^[@R20]^ Before disease onset, at 4 weeks of age, no significant difference in alpha diversity, beta diversity, or the relative abundance of the different phyla was found between WT and *Tnf^ΔARE/+^* mice ([Figure 5](#F5){ref-type="fig"}). After 8 weeks of age, a progressive increase in the relative abundance of *Firmicutes* was observed with a concomitant significant decrease in *Bacteroidetes* at 18 weeks of age. This progression was accompanied by a significant decrease in alpha diversity (species richness) and significant separation of WT mice from *Tnf^ΔARE/+^* mice by weighted UniFrac analysis ([Figure 5](#F5){ref-type="fig"}). These results indicate that the composition of the microbiome in the ileum of diseased *Tnf^ΔARE/+^* mice and co-housed WT control littermates is markedly different. Detailed analysis of the 16S rDNA sequencing data revealed the presence of 139 operational taxonomic units (OTUs) present across the different samples after filtering (average read fraction 92 ± 7%). At 4 and 8 weeks of age none of these OTUs was significantly different between co-housed *Tnf^ΔARE/+^* mice and WT littermate controls ([Figure 6](#F6){ref-type="fig"}, [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). At 18 weeks of age a significant dybiosis was observed between co-housed *Tnf^ΔARE/+^* mice and WT littermate controls. Out of the 139 OTUs detected, 23 were significantly different between WT and *Tnf^ΔARE/+^* mice. In *Tnf^ΔARE/+^* mice 20 out of 21 OTUs that were decreased in abundance were of the phyla *Bacteroidetes*. Two OTUs (greengenes id: 376862, 425767) were significantly increased in *Tnf^ΔARE/+^* mice compared to co-housed WT control-littermates ([Figure 6](#F6){ref-type="fig"}, [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). These two OTUs both belonged to the phylum *Firmicutes* and the genus *Candidatus* Arthromitus or *Candidatus* Savagella,^[@R21]^ informally known as Segmented Filamentous Bacteria (SFB). These results show that at 18 weeks of age, compared to co-housed WT littermate controls, *Tnf^ΔARE/+^* mice have an increased relative abundance of SFB in the terminal ileum.

The dysbiosis associated with loss of Paneth cells and defects in antimicrobial genes expression observed in diseased *Tnf^ΔARE/+^* mice, may affect not only the composition but also the number of mucosa-associated bacteria. We performed FISH analysis using a eubacterial probe on terminal ileal sections obtained from *Tnf^ΔARE/+^* and WT littermate controls. We observed an increased number of bacteria in direct contact with IECs in *Tnf^ΔARE/+^* mice compared to WT controls ([Figure 7a, b](#F7){ref-type="fig"}). To confirm these results we quantified the number of bacteria by pan-bacterial 16S rDNA qPCR analysis. While the levels of bacterial 16S rDNA in the stool were not significantly different between WT and *Tnf^ΔARE/+^* mice ([Figure 7c](#F7){ref-type="fig"}), an increased number of mucosa-associated bacteria was detected in *Tnf^ΔARE/+^* compared to WT animals ([Figure 7d](#F7){ref-type="fig"}). Similar results were obtained using SFB specific primers^[@R22]^ i.e. *Tnf^ΔARE/+^* mice showed an increase in the levels of mucosa-associated SFB ([Figure 7e](#F7){ref-type="fig"}). These results suggest that in diseased *Tnf^ΔARE/+^* mice an increased number of bacteria, likely SFB, are in close contact with IECs.

Modulation of the microbiota by antibiotics treatment reduces ileitis in *Tnf^ΔaRE/+^* mice {#S6}
-------------------------------------------------------------------------------------------

To determine if we can affect Crohn\'s-like disease progression by modulating the microbiota at an early disease stage, we treated *Tnf^ΔARE/+^* mice with water or with 0.5 g/L vancomycin in the drinking water. Antibiotic treatment was initiated at 6 weeks of age, an early disease stage when the first signs of pathology are observed, and maintained until analysis at 20 weeks of age, when full-blown disease is expected ([Figure 8a](#F8){ref-type="fig"}). Histopathological analysis showed severe Crohn\'s-like disease in *Tnf^ΔARE/+^* mice treated with water (n = 5). In contrast, none of the *Tnf^ΔARE/+^* mice treated with antibiotics (n = 5) showed signs of a Crohn\'s-like disease ([Figure 8b-d](#F8){ref-type="fig"}). These results establish the critical role of the microbiota in the progression of Crohn\'s-like IBD and also highlight the therapeutic potential of microbiota modulation by antibiotics when administered at the early stages of chronic intestinal inflammation.

Discussion {#S7}
==========

The results presented in this study collectively provide a mechanistic interpretation of the complex host-microbiota dialogue in Crohn\'s disease pathogenesis modeled in *Tnf^ΔARE/+^* mice. First, we show that Crohn\'s-like IBD pathology in the *Tnf^ΔARE^* model is microbiota-dependent, originating from TNF overexpression in the intestine which is driven by a normal, indigenous microbiota. Second, we show that Crohn\'s-like IBD pathology in *Tnf^ΔARE/+^* mice is associated with dampened antimicrobial responses and reduction of Paneth cells, mediated by adaptive immune system effectors. We further establish that secondarily to disease these conditions shape a dysbiotic gut microbiota in *Tnf^ΔARE/+^* mice which is not sufficient to transfer disease to co-housed WT mice but also involves increased abundance of epithelial-adhering SFB which may further promote disease.

Concerning our first conclusion that Crohn\'s-like IBD pathogenesis in *Tnf^ΔARE/+^* mice is microbiota-dependent, studies performed in other animal models of IBD, mainly in colitis models, have been controversial so far. Thus, an essential role in colitis pathogenesis has been shown for the microbiota in *IL-10^-/-^* mice and in HLA-B27 transgenic rats which were completely rescued from colitis under germ-free conditions.^[@R23],\ [@R24]^ In contrast, germ-free conditions attenuated but did not prevent spontaneous pathology in the *IL-2^-/-^* mouse model of colitis.^[@R25]^ The role of the microbiota in murine ileitis was examined so far only in the SAMP1/YitFc model in which germ-free conditions led to an attenuated phenotype but did not prevent pathogenesis.^[@R26]^ Consistently with the fact that adaptive immune effectors are a primary cause of disease in this model bearing transferable pathogenic activity,^[@R27]^ the persistence of the SAMP1/YitFc ileal pathology under germ-free conditions has been attributed to defects in immunoregulation.^[@R26]^ These studies indicate the presence of microbiota-independent mechanisms sufficient for IBD pathogenesis, particularly when adaptive immune responses are deregulated. In contrast, the microbiota is indispensable for the development of ileitis in the *Tnf^ΔARE^* model where innate and adaptive immune responses form a continuum. Although aberrant adaptive immune responses are an important component of the fully-developed IBD pathology in *Tnf^ΔARE/+^* mice,^[@R16]^ ileal pathology is observed in *Tnf^ΔARE/+^Rag1^-/-^* mice, involving infiltration of neutrophils and villi blunting.^[@R11],\ [@R13]^ Thus, germ-free studies in mouse models of IBD collectively suggest that the microbiota is indispensable for pathogenesis when deregulated inflammatory mechanisms predominate. By contrast, when aberrant adaptive immune responses are the major driver of disease, the microbiota appears to be dispensable for pathology initiation.

Our second conclusion is that Crohn\'s-like pathogenesis in *Tnf^ΔARE/+^* mice relies on the commensal microbiota whereas global changes in microbial communities, referred to as dysbiosis, are secondary to disease. This conclusion stems from our findings that significant alterations in gut microbiota composition at the level of phyla and at the level of the individual OTUs detected are observed only in late disease in *Tnf^ΔARE/+^* mice and thus appear not to be essential for the initiation of IBD pathogenesis. By contrast, the commensal microbiota is highly potent in inducing local TNF expression in the intestine of WT mice and TNF overexpression in the intestine of *Tnf^ΔARE/+^* mice at an early time-point, before disease onset. An important question raised by these findings is whether TNF transcriptional activation in the gut depends on specific bacterial taxa within the indigenous microbiota. Bacteria within commensals which are highly potent in inducing TNF transcriptional activation would function as pathobionts in the context of TNF-dependent ileitis in *Tnf^ΔARE/+^* mice,^[@R28]^ in a similar manner to the role played by *Prevotellaceae* in colitis susceptibility in *Nlrp6^-/-^* mice for example.^[@R29]^ The identification of such pathobionts could provide alternatives for localized targeting of TNF secretion in the gut. Thus, commensals or specific pathobionts within commensals, and not necessarily an overall dysbiotic microbiota, may be highly relevant to the early events initiating Crohn\'s disease, particularly in the presence of genetic variants which, either directly or indirectly, promote pro-inflammatory activation and local TNF expression in the gut.

Our present results however do not exclude a possible disease-exacerbating function of the dysbiotic microbiota developed in diseased *Tnf^ΔARE/+^* mice. In the *T-bet^-/-^RAG2^-/-^* mouse model of colitis the dysbiotic microbiota has been shown to be colitogenic and, interestingly, this activity is transferable even to WT mice.^[@R30]^ Although the dysbiotic microbiota of *Tnf^ΔARE/+^* mice is not sufficient to transfer pathology in co-housed WT mice, the findings in the *T-bet^\--/-^RAG2^-/-^* model indicate that the inflamed intestine may privilege the development of particularly harmful bacterial strains which may also bear full pathogenic potential. The increased abundance of SFB and their epithelial attachment in the inflamed ileum of *Tnf^ΔARE/+^* mice may contribute to disease perpetuation in this model. SFB have been shown to both induce Th17 cells in the LP and tightly adhere to the surface of epithelial cells in the terminal ileum of mice bearing Th17 cells.^[@R31]^ We have previously shown that *Tnf^ΔARE/+^* mice display increased Th17 responses in the ileal LP compared to WT controls.^[@R16]^ It is likely that the increased SFB abundance and their epithelial attachment in the ileum, reported here, underlies the increased Th17 responses in *Tnf^ΔARE/+^* mice.

The dysbiosis and the increased bacterial attachment on the epithelium observed in *Tnf^ΔARE/+^* mice secondarily to pathogenesis can be largely explained by the loss of Paneth cells and the associated disturbances in the expression of antimicrobial peptide genes. Paneth cells play a key role in intestinal antimicrobial surveillance, host defense and homeostasis and the involvement of Paneth cell dysfunction in IBD pathophysiology is under intense investigation, in light of GWAS results indicating abnormalities in Paneth cell function as risk factors for disease.^[@R3]^ Paneth cells in Crohn\'s disease patients have been shown to strongly overexpress TNF, a fact indicating that these cells have the potential to introduce inflammatory signals in the intestinal mucosa under some conditions.^[@R32]^ Reduced Paneth cell alpha defensins are observed in the ileum of Crohn\'s disease patients, though not in association with inflammation grade.^[@R33]^ In addition, in agreement with early reports,^[@R34]^ patients with active Crohn\'s disease have recently been shown to display reduced numbers of Paneth cells in their crypts, a defect suggested to result from increased necroptotic Paneth cell death.^[@R35]^ Whether loss of lysozyme^+^ cells in *Tnf^ΔARE/+^* mice reflects Paneth cell death or a dysfunction of alive Paneth cells needs to be addressed in future studies. It is likely that loss of lysozyme^+^ Paneth cells in *Tnf^ΔARE/+^* mice is caused by IFN-γ and TNF, both overproduced in their inflamed ileum. TNF has been shown to trigger Paneth cell necroptosis in mice bearing epithelial-specific caspase-8 ablation,^[@R35]^ whereas acute exogenous TNF administration in normal mice leads to Paneth cell dysfunction and loss of cellular integrity.^[@R36]^ In addition, IFN-γ produced during mucosal responses against the protozoan parasite *Toxoplasma gondii* leads to reduction of Paneth cells.^[@R37]^ IFN-γ is also a trigger for Paneth cell degranulation, epithelial extrusion and death, in organoids and *in vivo* upon anti-CD3 antibody injection.^[@R38]^ However, the physiological context of murine ileitis is markedly different from the above models; thus, the requirement of TNF and IFN-γ for Paneth cell loss should be directly examined by Paneth cell-specific ablation of the respective receptors in *Tnf^ΔARE/+^* mice.

A study published while our paper was under peer-review,^[@R39]^ showed that *Tnf^ΔARE^* ileitis is microbiota-dependent and associated with dysbiosis; results that are in agreement with our results. Schaubeck et al. also concluded that *Tnf^ΔARE^* ileitis is transmissible by disease-associated but not healthy microbiota. This conclusion was based on the fact that germ-free *Tnf^ΔARE/+^* mice developed ileitis upon caecal content transfer from diseased but not from non-responder (healthy) *Tnf^ΔARE/+^* mice present in their colony; transfer from WT mice was not tested. The authors did not explain, however, why diseased *Tnf^ΔARE/+^* mice did not transmit ileitis to the co-housed non-responders of the same litter, a fact that argues against a transmissible phenotype. Therefore, the evidence presented in the work by Schaubeck et al. was not firmly conclusive as to whether ileitis is transmissible in the *Tnf^ΔARE^* model by disease-associated but not healthy microbiota and that intestinal pathology is secondary to dysbiosis.

Our study establishes a mouse model of Crohn\'s disease in which the indigenous intestinal microbiota is causatively involved in pathogenesis under genetic conditions favoring TNF overexpression. In this model, dysbiosis is a result and not a cause of intestinal pathology. Future studies may clarify whether in humans the indigenous microbiota has the potential to play a similar pathogenic role in the presence of genetic conditions which favor inflammatory activation in the gut or affect the antimicrobial defenses that normally maintain commensals at check.

Methods {#S8}
=======

Mice, design of in vivo experiments and study approval {#S9}
------------------------------------------------------

Mice were bred and maintained on a C57BL6/J genetic background in the animal facilities of BSRC "Alexander Fleming" (for [Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4a-b](#F4){ref-type="fig"}) and the Icahn School of Medicine at Mount Sinai (for [Figures 4c-e](#F4){ref-type="fig"}, [@R5]-[@R8]) under specific pathogen-free conditions. As an exception, *Tnf^ΔARE+^Ifng^-/-^* mice were maintained on a mixed C57BL/6J×129Sv genetic background in the animal facilities of BSRC "Alexander Fleming". *Tnf^ΔARE/+^* mice,^[@R11]^ *Myd88^-/-^* mice,^[@R40]^ *Rag1^-/-^* mice^[@R41]^ and *Ifng^-/-^* mice^[@R42]^ have been previously described as indicated. For all in vivo experiments littermate and sex-matched mice were used. Mice were randomly assigned to experimental groups on a first-come basis. No mice were excluded from analyses performed. *Tnf^ΔARE/+^* mice were analyzed before disease onset (4 weeks) and/or at an intermediate (8 weeks), established (12 weeks) or full-blown (≥16 weeks) disease stage, based on the previously described disease course for this model in the animal facilities of BSRC "Alexander Fleming".^[@R13]^ A similar *Tnf^ΔARE/+^* disease course was observed in the animal facilities of Icahn School of Medicine at Mount Sinai as shown in [Supplementary Figure 3](#SD1){ref-type="supplementary-material"}.

All mice were used in accordance with the guidance of the Institutional Animal Care and Use Committee of BSRC "Alexander Fleming" and the guidelines of the Animal Care and Use Committee of Icahn School of Medicine at Mount Sinai.

Generation of germ-free *Tnf^ΔARE/+^* mice {#S10}
------------------------------------------

Germ-free mice were generated and raised at the Instituto Gulbenkian de Ciência, Oeiras, Portugal. C57BL6J *Tnf^ΔARE/+^* and WT mice were transferred to germ-free conditions upon rederivation by caesarean section, as described in the relevant EMMA protocol (<http://strains.emmanet.org/protocols/GermFree_0902.pdf>). Briefly, 20 days post-coitum donor females were euthanized and their uteri transferred to a sterile chamber through a reservoir filled with 1% Virkon S. Pups were extracted and adopted by C3H/HeN Germ-Free foster mothers. The microbiological status of the isolator and the animals were monitored 3 weeks after transfer and every 3 weeks onward. Germ-free and SPF control *Tnf^ΔARE/+^* mice were raised and maintained under strictly identical conditions, except the microbiological status. These include food pellets, drinking water, humidity and temperature.

Histopathological analysis of *Tnf^ΔARE/+^* mice {#S11}
------------------------------------------------

Histological analysis *of Tnf^ΔARE/+^* mice crossed with *Myd88^-/-^, Rag1^-/-^* and *Ifng^-/-^* mice and of germ-free *Tnf^ΔARE/+^* mice was performed in the terminal ileum as described previously.^[@R12]^ The proximal and distal colon was also examined. Briefly, the tissue was embedded in paraffin and stained with H&E. Semi-quantitative assessment of intestinal pathology was performed in a blinded fashion. The following scoring system was used: 0= normal, 1= villi blunting and mucosal inflammation, 2= villi blunting, extensive mucosal inflammation and submucosal inflammation, 3= extensive submucosal inflammation, 4= transmural inflammation.

Pan-bacterial PCR amplification {#S12}
-------------------------------

Total genomic DNA was isolated from tissue using the DNeasy Blood & Tissue Kit (Qiagen). Quantitative PCR analysis and SFB primer sequences are described elsewhere.^[@R43]^ Relative quantity was calculated by the ΔCt method and normalized by the presence of mouse ubiquitin.

Biome analysis {#S13}
--------------

DNA was obtained from distal ileum (2 cm) using the DNeasy Blood and Tissue Kit (QIAGEN). Bacterial 16S rRNA genes were amplified using the primers as described.^[@R44]^ Sequencing was performed with an Illumina MiSeq sequencer for sequencing as previously described.^[@R44]^ Detailed methods for DNA Extraction, 16S rDNA Amplification, Multiplex sequencing and Analysis of 16S rDNA Sequences are provided in the Supplementary Methods.

Antibiotic treatment {#S14}
--------------------

Mice were treated for the indicated time with 0.5 g/L vancomycin (Western Medical Supply) ad libitum in the drinking water for the indicated time.

Statistical analyses {#S15}
--------------------

For graphs and statistical analyses indicated we used GraphPad Prism, SigmaPlot or R statistical environment. Sampling distributions were tested for normality with a threshold of alpha=0.05 (GraphPad Prism). For *P*\<0.05 in the normality test, differences in means were tested for statistical significance with two-tailed Mann-Whitney *U* test (Wilcoxon rank-sum test). For *P*\>0.05 in the normality test, F test or Bartlett\'s test were used for homoscedasticity. For similar variances (F test, *P*\>0.05) unpaired two-tailed Student\'s t-test was applied, for unequal variances (F test, *P*\<0.05) unpaired two-tailed Welch\'s t-test was applied. *P*-values \<0.05 were considered as statistically significant.
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Supplementary Figure S1: Paneth cell quantification in *Tnf^ΔARE/+^Rag1^-/-^* mice and *Tnf^ΔARE/+^Ifng^-/-^* mice.

**(a)** Paneth cell number reduction in the terminal ileum of 16-week-old *Tnf^ΔARE/+^* mice is prevented by genetic ablation of Rag1. Representative pictures from immunohistochemistry against Lysozyme are shown (n=3/group). (Scale bars: 50 μm).

**(b)** Paneth cell number reduction in the terminal ileum of 16-week-old *Tnf^ΔARE/+^* mice is prevented by genetic ablation of IFN-γ. Representative pictures from immunohistochemistry against Lysozyme are shown (n=3/group). (Scale bars: 50 μm). As an exception in this study, *Tnf^ΔARE/+^Ifng^-/-^* mice were maintained on a mixed C57BL/6J×129Sv genetic background instead of C57BL6/J.

**(c)** Quantification of Paneth cells per crypt section in the 16-week-old *Tnf^ΔARE/+^Rag1^-/-^* mice and 16-week-old *Tnf^ΔARE/+^Ifng^-/-^* mice described in (a) and (b) in comparison to the respective littermate *Tnf^ΔARE/+^* controls. At least n=100 crypts from n=3 mice per group were examined. Data shown represent mean ± SEM. Statistical significance was calculated by two-tailed Mann-Whitney test (\*\*\* *P* \< 0.001).

**Supplementary Figure S2**: Heatmap for all detected 139 OTUs across all samples. OTUs that were significantly altered in the terminal ileum of *Tnf^ΔARE/+^* compared to co-housed WT littermate controls at 4, 8 and 18 weeks (4 weeks: WT (n = 6), *Tnf^ΔARE/+^* (n = 9); 8 weeks: WT (n = 9), *Tnf^ΔARE/+^* (n = 7); 18 weeks: WT (n = 19), *Tnf^ΔARE/+^* (n = 20) are indicated by the right colored boxes (blue, *P* \< 0.05). Each column represents a different mouse. Left colored boxes indicate the phyla classification (T).

Supplementary Figure S3: Crohn\'s-like IBD pathology in the terminal ileum of *Tnf^ΔARE/+^* mice at different ages.

Histological analysis of the terminal ileum of *Tnf^ΔARE/+^* mice raised in the animal facilities of the Icahn School of Medicine at Mount Sinai, at the age of 4, 8 and 18 weeks. (Scale bars: 50 μm).

We thank S. Lalos and A. Katevaini for technical assistance in histology and J. Bom for animal care and rederivation of mice to germ-free conditions. We would also like to acknowledge the contribution of our colleague Maria Apostolaki (deceased December 10, 2010) in the design of this study and the original Myd88 knock-out results. This work was funded by ERC project MCs-inTEST (340217) and European Community\'s Innovative Medicines Initiative (IMI)-funded project BeTheCure (115142-2) to G.K. and the NIH grant P01 DK072201 and CCFA research grant (\#330239) to S.A.L. Mice axenization was supported by the EC FP7 funded research infrastructure INFRAFRONTIER-I3/EMMA. Endoscopy experiments have been supported by the Deutsche Forschungsgemeinschaft (SPP1656, SFB 796, KFO 257 CEDER) and the IMI, acronym BeTheCure (115142) to C.B. Measurements of paracellular permeability at Hannover Medical School were financed by the Sonderforschungsbereich SFB 621/C9 and DFG grant SE460/13-4 to U.S. The authors also thank the InfrafrontierGR Infrastructure, co-financed by the ERDF and NSRF 2007-2013, for animal housing, histopathology and imaging services.
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![Germ-free *Tnf^ΔARE/+^* mice are completely rescued from TNF overexpression in the intestine and Crohn\'s-like IBD pathology\
**(a)** Histological analysis was performed in the terminal ileum of n = 6 *Tnf^ΔARE/+^* mice raised under germ-free conditions at the age of 15 weeks. N = 7 *Tnf^ΔARE/+^* mice raised under Specific Pathogen Free (SPF) conditions (11 weeks) were used as controls. Representative H&E-stained sections are shown. (Scale bars: 100 μm).\
**(b)** Histopathological analysis performed in the terminal ileum of germ-free and SPF control *Tnf^ΔARE/+^* mice examined at the age of 15 and 11 weeks respectively. Statistical significance was calculated by Kruskal-Wallis one-way analysis of variance.\
**(c)** Quantification of TNF gene expression in whole tissue biopsies from the terminal ileum of *Tnf^ΔARE/+^* mice reared under germ-free and SPF conditions, examined at the age of 15 and 11 weeks respectively. Statistical significance was calculated with two-tailed Mann-Whitney test.\
All data shown represent mean ± SEM.](nihms722769f1){#F1}

![Myd88 mediates TNF overexpression and IBD pathogenesis in *Tnf^ΔARE/+^* mice\
**(a)** Crohn\'s-like pathology is attenuated in the terminal ileum of 16-week-old *Tnf^ΔARE/+^Myd88^-/-^* mice as compared to *Tnf^ΔARE/+^* littermate controls. Representative H&E-stained sections are shown. (Scale bars: 50 μm).\
**(b)** Histopathological analysis performed in the terminal ileum of *Tnf^ΔARE/+^Myd88^-/-^* and *Tnf^ΔARE/+^* control mice at the age of 16 weeks. Statistical significance was calculated with Mann-Whitney test. (\*\* *P* \< 0.01)\
**(c)** Thioglycollate-elicited peritoneal macrophages (see SI Methods) were isolated from 16-week-old *Tnf^ΔARE/+^*, *Tnf^ARE/+^Myd88^-/-^*, *Myd88^-/-^* and WT control mice (n = 3 mice per genotype) and stimulated with LPS for 6 hours. TNF secretion was measured by ELISA. Macrophages isolated from *Tnf^ΔARE/+^Myd88^-/-^* mice show defective LPS-induced TNF secretion. Statistical significance was calculated with unpaired Welch t test. (\*\* *P* \< 0.01)\
All data shown represent mean ± SEM.](nihms722769f2){#F2}

![Epithelial barrier function in the ileum of diseased *Tnf^ΔARE/+^* mice\
**(a)** Endoscopic pictures from the terminal ileum of 12 week-old *Tnf^ΔARE/+^* mice and WT controls. Representative of n = 2 independent experiments.\
**(b)** Quantification of intraepithelial lymphocytes (IELs) isolated from the ileum of 12 week-old *Tnf^ΔARE/+^* mice and WT controls (n=5 each). Unpaired two-tailed Student *t*-test (\*\*\* *P* \< 0.001)\
**(c)** Epithelial paracellular permeability, as measured by blood to lumen ^51^Cr-EDTA clearance in the terminal ileum of 12 week-old *Tnf^ΔARE/+^* mice (n=4) and WT controls (n=4). No significant difference (ns) was found between the two groups by Two-way ANOVA.\
**(d)** Epithelial barrier permeability of 12 week-old *Tnf^ΔARE/+^* mice (n=7) and WT controls (n=6), as measured by lumen to blood passage of orally-delivered 20kDa FITC-dextran.\
**(e)** Stool water content of *Tnf^ΔARE/+^* mice (n=24) and WT littermates (n=18) at the age of 16 weeks. No significant (ns) differences were found by unpaired two-tailed Student *t*-test.\
**(f-g)** Goblet cell numbers and mucus secretion show no major defects in the inflamed ileum of 12-week-old *Tnf^ΔARE/+^* mice compared to littermate WT controls (n=3 per group) as shown by Periodic acid-Schiff (PAS)-staining **(e)** and mucin 2 immunostaining **(f)**. Unpaired two-tailed Student *t*-test. (Scale bars: 50 μm).](nihms722769f3){#F3}

![Loss of Paneth cells and altered expression of antimicrobials in the ileum of diseased *Tnf^ΔARE/+^* mice\
**(a)** Immunohistochemistry for Lysozyme for the quantification of Paneth cells per crypt in the terminal ileum of *Tnf^ΔARE/+^* mice at the age of 8 and 16 weeks and littermate WT controls (n=3/group). Two-tailed Mann-Whitney test (\*\*\* *P* \< 0.001).\
**(b)** Paneth cell numbers are significantly reduced as the local IBD histopathological score increases in the crypts of 8 week-old *Tnf^ΔARE/+^* mice (n=3). A total of n=108 well-oriented crypts were examined. Indicative lysozyme immunostaining pictures are shown for each disease stage. (Scale bars: 33 μm). Statistical significance was calculated by two-tailed Mann-Whitney test (\*\* *P* \< 0.01).\
**(c)** Relative mRNA expression of *Defa21* in the last 2 cm of the terminal ileum of WT and *Tnf^ΔARE/+^* mice at different ages (n= 4-8/group). Two-tailed Student *t*-test.\
**(d)** Relative expression of antimicrobials *Cr2*, *Defa29* and *Lyzc1* in whole tissue extracts from the last 2 cm of the ileum of WT and *Tnf^ΔARE/+^* mice at 18 wks (n= 6/group). Two-tailed Student *t*-test.\
**(e)** Relative expression of *Tnf* in whole tissue extracts from the last 2 cm of the ileum of WT and *Tnf^ΔARE/+^* mice at different ages (n= 4-8/group). Two-tailed Student *t*-test.\
R.E., Relative Expression. Each dot represents an animal. All data shown represent mean ± SEM.](nihms722769f4){#F4}

![Biome analysis of *Tnf^ΔARE/+^* mice\
**(a)** Relative abundance of phyla present in the terminal ileum of WT and *Tnf^ΔARE/+^* mice at 4 (W, n = 6; T, n = 9), 8 (W, n = 9; T, n = 7), and 18 (W, n = 19; T, n = 20) weeks of age. Data shown represent the most abundant phyla, while low abundant and unclassified OTUs were grouped in 'Other', \* represents a significant (q \< 0.05) change in abundance between age-matched WT and *Tnf^ΔARE/+^* mice.\
**(b)** Alpha diversity in *Tnf^ARE/+^* mice at 4, 8 and 18 weeks of age. Statistical significance was calculated with Mann-Whitney test.\
**(c)** Weighted Unifrac distances between *Tnf^ΔARE/+^* and co-housed WT litter-mate controls at 4, 8 and 18 wks of age. Statistical significance was calculated with Adonis test.](nihms722769f5){#F5}

![Increased abundance of *Candidatus* Arthromitus in *Tnf^ΔARE/+^* mice\
**(a)** In total 139 OTUs were detected across all samples. Pearson hierarchical clustering of the abundance profiles of the 23 OTUs that were significantly altered in the terminal ileum of *Tnf^ΔARE/+^* mice compared to co-housed WT littermate controls at 4, 8 and 18 weeks. 4 weeks: WT (n = 6), *Tnf^ΔARE/+^* (n = 9); 8 weeks: WT (n = 9), *Tnf^ΔARE/+^* (n = 7); 18 weeks: WT (n = 19), *Tnf^ΔARE/+^* (n = 20). Two OTUs, 376862 and 425767, were significantly enriched at 18 weeks; both represent the genus *Candidatus* Arthromitus. Each column represents a different mouse. Left colored boxes indicate the family/genus taxonomy classification (T). Right colored boxes indicate if the comparison (p) between WT and *Tnf^ΔARE/+^* shows significant difference (blue, *P* \< 0.05). **(b)** LOESS regression of the median read counts of the S24-7/- and Clostridiaceae/Candidatus Arthromitus OTUs shown in (a). Shaded region represents standard error. **(c)** Boxplots showing the relative abundance of the two OTUs (376862, 425767) enriched in *Tnf^ΔARE/+^* mice at 18 weeks of age.](nihms722769f6){#F6}

![Increased number of mucosa-associated bacteria in the terminal ileum of *Tnf^ΔARE/+^* mice\
**(a-b)** Visualization of bacterial localization in the distal ileum of WT and *Tnf^ΔARE/+^* mice at 18 wks. Transversal sections of the distal ileum were hybridized with a eubacterial 16S probe (red) and counterstained with Pan-keratin antibody to visualize the intestinal epithelial cells (green) and DAPI for nuclear staining (blue). Notice the increased attachment of bacteria to the epithelium of *Tnf^ΔARE/+^* mice when compared to WT animals. Shown are representative images **(a)** and quantification of 5 mice per group **(b)**.\
**(c-d)** Bacterial content in the stool **(c)** and in the distal ileum mucosa **(d)** of WT (n = 4) and *Tnf^ΔARE/+^* mice (n = 5) at 18 wks of age determined by pan-bacterial 16S qPCR amplification relative to host ubiquitin.\
**(e)** Relative expression of mucosa-associated SFB in the terminal ileum of WT and *Tnf^ΔARE/+^* mice at 18 weeks of age.\
R.E., Relative Expression. Each dot presents an animal. Data are expressed as mean ± SEM. Statistical significance was calculated with two-tailed Student *t*-test. Scale bars = 50 μm.](nihms722769f7){#F7}

![Antibiotics treatment rescues ileitis in *Tnf^ΔARE/+^* mice\
**(a)** Diagram of antibiotic treatment. *Tnf^ΔARE/+^* mice at 6 weeks of age were treated with water (n=5) or vancomycin (n=5). Animals were sacrificed at 20 weeks of age. Inflammatory infiltrates in the ileum of *Tnf^ΔARE/+^* mice were completely abrogated in animals treated with vancomycin **(c)** when compared to water treated controls **(b)**. All mice (n = 5 per group) were analyzed histologically and representative H&E-stained sections are shown.\
**(d-e)** Immunostaining of CD45 and Pan-keratin in the terminal ileum of *Tnf^ΔARE/+^* mice treated with water (n = 5) **(d)** or vancomycin (n =5) **(e)**, sacrificed at 20 weeks of age.\
**(f)** Ileitis incidence in 20-week-old *Tnf^ΔARE/+^* mice treated with water (n = 5) or vancomycin (n = 5).](nihms722769f8){#F8}
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